Overview
Daniel Lee is a Nuclear Medicine provider practicing medicine in Houston, Texas.
His clinical expertise encompasses Lung Nodules, Pancreatic Ductal Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- HMO
- INDEMNITY
- POS
- PPO
Locations
6565 Fannin St, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sightline Of Atlanta LLP
Ebrahim Delpassand is a Nuclear Medicine provider practicing medicine in Houston, Texas. Dr. Delpassand is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Pancreatic Ductal Adenocarcinoma, Lacrimal Gland Tumor, and Liver Embolization.
Office
Aaron Jessop is a Nuclear Medicine provider practicing medicine in Houston, Texas. Dr. Jessop is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melorheostosis with Osteopoikilosis, Melorheostosis, Osteopenia, and Lung Nodules.
UT MD Anderson Cancer Center
Devaki Surasi is a Nuclear Medicine provider practicing medicine in Houston, Texas. Dr. Surasi is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.
Frequently Asked Questions about Dr. Daniel Lee
How do I make an appointment with Dr. Daniel Lee?
You can book an appointment with Dr. Daniel Lee by calling their office at 713-441-4355. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Daniel Lee a top-rated expert for Lung Nodules?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel Lee is classified as an Experienced expert for Lung Nodules, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Daniel Lee specialize in?
While Dr. Daniel Lee is a Nuclear Medicine, they have specific expertise in Lung Nodules, Pancreatic Ductal Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nuclear Medicine.
Does Dr. Daniel Lee participate in research or clinical trials?
Yes. Dr. Daniel Lee has published 4 articles and abstracts on conditions like Lung Nodules. You can view a list of Dr. Daniel Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Daniel Lee accept my insurance?
Dr. Daniel Lee accepts most major insurance plans, including Community Health and Humana. We recommend calling the office directly at 713-441-4355 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Lung NodulesDr. Lee isExperienced. Learn about Lung Nodules.
- Pancreatic Ductal AdenocarcinomaDr. Lee isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.